Akebia Therapeutics, Inc.

Historical 13F Holders

Symbol
AKBA
CUSIP
00972D105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 00972D105 since 12/18/2024, newest first.

Filer % of Class Filed
State Street Corp 13G 4.3% 5/12/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 1 0% 3/26/2026
Event 3/13/2026
State Street Corp 13G 5.2% 2/9/2026
Event 12/31/2025
BlackRock, Inc. 13G/A Amendment 2 7.2% 1/21/2026
Event 12/31/2025
Vanguard Group Inc 13G 5.4% 4/30/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 1 6.1% 4/17/2025
Event 3/31/2025
Satter Muneer A 13G/A Amendment 3 2.6% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 18 1.28 M $1.18 M
2026 Q2 179 110 M $129 M
2026 Q1 178 102 M $141 M
2025 Q4 174 118 M $190 M
2025 Q3 184 125 M $340 M
2025 Q2 165 109 M $395 M
2025 Q1 153 95.6 M $203 M
2024 Q4 132 68.1 M $129 M
2024 Q3 123 59.5 M $78.5 M
2024 Q2 113 57.1 M $58.3 M
2024 Q1 131 58.6 M $107 M
2023 Q4 98 55.5 M $73.6 M
2023 Q3 83 50.9 M $58.0 M
2023 Q2 86 50.3 M $46.0 M
2023 Q1 71 52.0 M $30.9 M
2022 Q4 83 52.8 M $31.2 M
2022 Q3 98 52.2 M $16.5 M
2022 Q2 106 57.5 M $20.2 M
2022 Q1 151 81.3 M $58.4 M
2021 Q4 148 98.0 M $221 M
2021 Q3 134 98.5 M $284 M
2021 Q2 150 106 M $402 M
2021 Q1 158 101 M $340 M
2020 Q4 162 106 M $301 M
2020 Q3 180 102 M $268 M
2020 Q2 203 112 M $1.52 B
2020 Q1 169 92.9 M $704 M
2019 Q4 166 86.1 M $544 M
2019 Q3 164 85.3 M $334 M
2019 Q2 171 87.2 M $422 M
2019 Q1 183 84.8 M $695 M
2018 Q4 179 82.1 M $454 M
2018 Q3 142 42.8 M $378 M
2018 Q2 152 43.0 M $537 M
2018 Q1 158 43.9 M $416 M
2017 Q4 136 33.7 M $501 M
2017 Q3 124 30.2 M $593 M
2017 Q2 124 27.3 M $392 M
2017 Q1 97 21.7 M $199 M
2016 Q4 103 21.0 M $219 M
2016 Q3 96 19.6 M $177 M
2016 Q2 107 19.6 M $147 M
2016 Q1 100 21.1 M $191 M
2015 Q4 98 16.3 M $209 M
2015 Q3 86 18.7 M $184 M
2015 Q2 76 13.1 M $146 M
2015 Q1 64 7.47 M $88.3 M
2014 Q4 58 7.56 M $94.5 M
2014 Q3 55 8.01 M $180 M
2014 Q2 53 8.74 M $243 M
2014 Q1 3 104 k $2.03 M